Skip to main content
Human Vaccines & Immunotherapeutics logoLink to Human Vaccines & Immunotherapeutics
. 2023 May 11;19(1):2211495. doi: 10.1080/21645515.2023.2211495

Hesitant or not: A cross-sectional study of socio-demographics, conspiracy theories, trust in public health information, social capital and vaccine hesitancy among older adults in Ghana

Anthony Kwame Morgan a,b,, Modesta Akipase Aziire c, Justin Cobbold a, Agnes Adzo Agbobada b, Senyo Kossi Kudzawu d
PMCID: PMC10177693  PMID: 37165968

ABSTRACT

Vaccination is an effective strategy to reduce the coronavirus disease 2019 (COVID-19) burden, but its effectiveness hinges on timely vaccine uptake. Addressing concerns among vaccine-hesitant individuals is critical to preventing the immunization program from failing. This study analyzes the determinants of vaccine hesitance among older adults (aged 50 years and older) in Ghana. We adopted a cross-sectional survey with a quantitative approach that accessed data from 400 older adults from the Accra and Kumasi metropolitan areas using purposive and snowball sampling techniques. Multivariate logistic regressions were used to estimate the socio-demographic, social capital, conspiracy theories about COVID-19, and public health information factors associated with vaccine hesitance within the sample. The study found that only minority (5%) of respondents had been vaccinated, with 79% indicating willingness to be vaccinated. The study found that females (AOR: 0.734, CI: 0.019–0.036, p = .027) and those who have retired (AOR: 0.861, CI: 0.003–0.028, p = .034) were significantly less likely to engage in COVID-19 vaccine hesitance. Furthermore, the study revealed that participants who trust public health information (AOR: 0.065, CI: 0.022–0.049, p = .031) and have social capital (AOR: 0.886, CI: 0.017–0.032, p = .001) were significantly less likely to present COVID-19 vaccine hesitance. Finally, participants who believe in conspiracy theories about COVID-19 and vaccines (AOR: 3.167, CI: 1.021–2.043, p = .004) were significantly more likely to engage in COVID-19 vaccine hesitance. Efforts to convey vaccination benefits and address issues through evidence-based information are needed to strengthen and preserve the public’s trust in vaccines in Ghana.

KEYWORDS: Conspiracy theories, public health information, social support, vaccine hesitancy, Ghana

Introduction

The coronavirus disease 2019 (COVID-19) pandemic, caused by SARS-CoV-2, has affected over 418 million individuals in over 150 countries. More than 171,172 confirmed cases with 1,462 fatalities have been recorded in Ghana as of February 17, 2023.1 The pandemic continues to pose a danger to healthcare systems across the globe.2–5 Several vaccines for emergency immunization have been produced and certified to date.6–9 At least one dose of the COVID-19 vaccine has been administered to 69.7% of the world’s population. Globally, 13.31 billion doses have been given; now, 1.05 million are given per day. People in low-income countries make up 27.7% of the vaccinated population.10 In Ghana, 22,384,226 vaccine doses have been administered according to the World Health Organisation [WHO].11 There are still safety concerns, especially in light of potential negative effects, even though the advantages of vaccinations in preventing the spread and COVID-19-induced deaths12 are documented, notably among vulnerable groups.13 Although more severe reactions have only sometimes been documented,14 these reactions are often moderate and transient. There is still a lot of doubt about the COVID-19 vaccination, despite the successful outcomes of vaccinations and intense public health efforts to implement immunization programs.15 As a result, it is critical to adopt techniques to foster trust in the general populace16 by informing people about the advantages of receiving the COVID-19 vaccine and dispelling myths.17 This will go a long way to address COVID-19 vaccine hesitancy.

Addressing concerns among vaccine-hesitant individuals, on the other hand, is critical to preventing the immunization programme from failing.18 This provides some promise for reducing the spread of COVID-19 infection. Countries and governments throughout the world have invested billions of dollars to prepare for the immunization of their populations.18 Vaccination programmes can result in herd immunity without requiring a significant proportion of the population to be infected.19 However, for such immunity to be achieved, a large enough fraction of the population must be immunized. Immunization programmes are only effective when the vaccine is widely accepted.20,21 This brings into focus the need to examine the factors that influence vaccine hesitance.

Studies from around the world have produced mixed results and identified several factors that influence hesitance toward COVID-19 vaccine uptake. These include disease risk perception, vaccine safety and efficacy perception, and general vaccination attitudes.22 Previous vaccination history, doctor’s recommendations, prices of vaccines, vaccination convenience, and sociodemographic features.23,24 Other reasons include poor trust in the COVID-19 vaccine and the healthcare response during the pandemic, aperception of government initiatives, and a perception of the information presented as inconsistent and contradictory.25–27 Governments, public health experts, and advocacy groups must be ready to confront skepticism and increase vaccination knowledge so that the public will embrace immunization when necessary.21 However, to adopt widespread COVID-19 immunization programmes, researchers must continue to explore vaccine hesitance, and health education must be planned ahead of time to address any concerns that may develop during the programme.18

Social capital, the quality of connections among community members, as evidenced by trust and reciprocal support that benefits all parties—has been shown to promote vaccination uptake and reduce vaccine hesitance.29–31 These studies suggest that vaccine resistance decreases with increasing social capital in the form of trust in the healthcare system. According to the findings of a study by Machida et al.32 in Japan, people with higher levels of social capital on an individual basis are more likely to take up a COVID-19 vaccine than those with lower levels of social capital. It, therefore, suggests that during a pandemic, social capital may help to overcome vaccination hesitance.

Several researchers have conducted studies on COVID-19 vaccination uptake and hesitancy in Ghana. These studies were focused on the general population33,34 and healthcare workers,35,36 with no specialized studies conducted on the elderly, who are the demographic group most impacted by the COVID-19 pandemic. Furthermore, rumors and conspiracy theories, which cause distrust and contribute to vaccination hesitance, were not considered a predictor in these studies.37 To properly track COVID-19 vaccine disinformation in real-time and engage with social media to communicate accurate information, which might help protect the public from misinformation, their effect [misinformation, rumors, and conspiracy theories] must be investigated. Furthermore, social capital, an important component in explaining differences in public behavior during health crises that may help determine policies in local communities,25 was not included in previous studies that investigated the willingness of the Ghanaian population to accept COVID-19 vaccine.

We examined the socio-demographics, social capital, conspiracy theories, and faith in public health services and information as predictors of COVID-19 vaccination hesitance among older adults in Ghana’s Greater Accra and Kumasi Metropolitan Areas. Why older adults? The aged are more vulnerable to severe illness and death from COVID-19 due to age-related declines in the immune system, known as immunosenescence. Additionally, older adults are more likely to have underlying health conditions that increase their risk of severe COVID-19, such as hypertension and chronic obstructive pulmonary disease. Investigating vaccine hesitancy within older adults can aid in developing policies and measures to promote vaccine uptake and reap its associated benefits. The knowledge gained from such investigations can assist the government of Ghana and other health agencies in targeting their campaigns towards addressing the obstacles to the COVID-19 mass immunization programme's successful implementation, especially for older adults, and ultimately improving vaccination rates among all citizens.

Materials and methods

Setting

The study was conducted in the Accra Metropolis and the Kumasi Metropolis, two of Ghana’s 261 Metropolitan, Municipal, and District Assemblies (MMDAs). The Accra Metropolis has an estimated population of 2,605,000, while the Kumasi Metropolis has a population of 3,768,000. These two cities also coincide as the most affected by the COVID-19 pandemic in terms of the number of cases recorded. Again, they have the highest population of the country’s older adults, perfectly making them ideal study areas.

Research design

The study was underpinned by the quantitative approach which offers prospects for establishing relationships among variables38,39 since it comprises the application of rigorous statistical analysis.40,41 With this approach, it was possible to quantify the responses of the respondents to generalize. To achieve this, the study adopted a cross-sectional survey design that helped collect data on the factors that predict COVID-19 vaccine hesitancy among older persons within the Accra and Kumasi Metropolitan areas of Ghana’s Greater Accra and Ashanti Regions respectively. Cross-sectional research provides a picture of the results and the traits associated with it, at a particular period in time.42–44 It was used to estimate the odd ratios to study the association between exposure and the outcome variables.43 The exposure variables in this study are socio-demographic characteristics of older adults, belief in conspiracy theories, and trust in public health information in addition to access to social capital whereas the outcome variable is COVID-19 vaccine hesitancy.

Sources of data and sample size

Primary data was obtained from older adults (50 years and above). The sample size was calculated using the single proportion formula without continuity correction: n = Z2 *P(1-P)/d2.45 The following assumptions were made: the proportion (P) was assumed to be 0.5 in the absence of past studies, the Z statistic for a 95% confidence level of confidence (Z = 1.96), and the degree of precision (d = 0.05 in a proportion of 1). This yielded a sample of 384. An additional 79 respondents were added to the sample at a 20% non-response rate. At an 86.4% response rate, the 463 people reached filled out 400 questionnaires. Without a sampling frame, the 400 respondents were sampled using the purposive46,47 and the snowballing48,49 approaches. The use of these sampling techniques were premised on the difficulty in locating older adults. Inclusion criteria were that the respondent (i) was 50 years and above; (ii) willing to be interviewed (iii) willing to voluntarily provide informed consent to participate in the study (v) able to communicate in English language, Ga, and Ashanti Twi – the commonly spoken languages in the study areas. Participants excluded were those who were sick at the time of the study and those with communication or speech disabilities.

Data collection instrument

To improve the response rate, a close-ended questionnaire was used to gather the data.50 Researchers in the social and health sciences, as well as market research, commonly utilize questionnaires. They often use closed-ended questions with a well-designed format because they are easy to comprehend and have quick responses. However, some criticize closed-ended questionnaires for potentially overlooking vital information pertinent to the responses. Despite this, a close-ended questionnaire developed from exhaustive literature is equally good as a partially closed one. To avoid these issues, we adopted a fully closed-ended approach. We structured the questionnaire into six sections. The first covered socio-demographic characteristics;51,52 the second, vaccine hesitancy;53,54 and the third, social capital. Believe in conspiracy theories and trust in public health information were captured under sections four and five respectively.

Data collection procedure

Eight research assistants collected the data between June 2021 and August 2021. In most instances, the respondents filled out the questionnaire themselves, while in some instances, the researcher-administered questionnaire approach was used. The self-administered questionnaires were sent to the respondents by mail and text (the WhatsApp messaging application). The respondents filled and Google Forms, which were embedded within e-mails and texts. For the researcher-administered questionnaires, the research assistants interviewed the respondents at predetermined locations, mainly their homes and in a few situations, their workplaces. The research assistants ticked their responses. The researcher-administered approach was used, mainly for persons who had no literacy in English.

Data analysis

The online data in excel format was downloaded, edited and checked for completeness and consistency. It was exported to Statistical Package for the Social Sciences (SPSS) version for analysis. Descriptive statistical tools such as frequencies and percentages were used to summarize the socio-demographic characteristics of the respondents, while the Chi-square analysis was used to establish the association between the socio-demographic characteristics of the respondents and the prevalence of vaccine hesitance. The binary logistic regression model embedded in the SPSS software was used to establish the factors that predict vaccine hesitancy. The results were considered significant at an alpha of 0.05 or less. Model 1 = Socio-Demographic variables (gender, age, religion, marital status, level of education and employment); Model 2 = All variables in Model 1 plus Trust in health information and social capital-related variables (gender, age, religion, marital status, level of education and employment, believe in conspiracy theories, trust in public health information and social capital).

Ethical consideration

The study met all ethical requirements. To begin, the concept of voluntary consent55 as it relates to social science research was followed during the data collection process. The purpose of the study and the usage of the data collected was explained to the respondents. Second, when reporting the findings of the respondents, anonymity and privacy was ensured.

Results

Prevalence of vaccine hesitancy

In Table 1, a disaggregated prevalence of the COVID-19 vaccine hesitance alongside the socio-demographic characteristics of the respondents is presented. Four hundred older adults were involved in this study. Of the 400 participants, 218 (54.5%) reside within the Kumasi Metropolis, 151 (37.8%) of them were males, and 249 (62.3%) were females. Up to 211 (52.8%) of the participants were aged between 50–60 years, 149 (37.2%) were aged between 61–70 years, and 40 (10%) were above 70 years. Among the participants, 331 (82.8%) were Christians, 229 (57.3%) were married, 121 (31%) had primary or basic education, 250 (62.5%) were employed (either by an entity-state or private institution or are self-employed), 157 (39.3%) were quite well off (based on self-reported social status ranking) among others (see Table 1 for further details). There was a significant association between socio-demographic characteristics such as religious affiliation, level of education and employment status on the one hand and vaccine hesitance on the other hand (P-value < .05). However, no association was established between location, gender, age, marital status and socioeconomic status, health insurance enrollment and vaccine hesitance among the respondents (P-value > .05).

Table 1.

Vaccine hesitancy according to associated socio-demographics.

Variables Vaccine Hesitance
Total (%) P-value
Yes No
Location Greater Accra Metropolis
Kumasi Metropolis
105 (45.3)
127 (54.7)
77 (45.8)
91 (54.2)
182 (45.5)
218 (54.5)
.497
Gender Males
Females
82 (35.3)
150 (64.7)
70 (41.7)
98 (58.3)
152 (38.0)
248 (62.0)
.119
Age (years) 50–60 years
61-70years
Above 70 years
125 (53.9)
85 (36.6)
22 (9.5)
86 (51.2)
64 (38.1)
18 (10.7)
211 (52.8)
149 (37.2)
40 (10)
.845
Religion Christian
Non-Christian
178 (76.7)
54 (23.3)
153 (91.1)
15 (8.9)
331 (82.8)
69 (17.2)
< .001*
Marital Status Married
Divorced
Widowed
127 (54.7)
45 (19.4)
60 (25.9)
102 (60.7)
34 (20.2)
32 (19.0)
229 (57.2)
79 (19.8)
92 (23.0)
.271
Level of Education No formal education
Basic education
High school education
Tertiary education
49 (21.1)
75 (32.3)
41 (17.7)
67 (28.9)
21 (12.5)
49 (29.2)
58 (34.5)
40 (23.8)
70 (17.5)
124 (31.0)
99 (24.8)
107 (26.8)
.001*
Employment Employed
Retired
232 (100)
0 (0)
18 (10.7)
150 (89.3)
250 (62.5)
150 (37.5)
< .001*
Perceived socio-economic status Extremely poor
Quite poor
Not very well off
Quite well off
41 (17.7)
86 (37.1)
76 (32.8)
29 (12.5)
27 (16.1)
71 (42.3)
45 (26.8)
25 (14.9)
68 (17.0)
157 (39.2)
121 (30.2)
54 (13.5)
.498

P-value < .05.

* = a statistically significant result.

Associated factors of COVID-19 vaccine hesitancy

Table 2 presents the associated factors of COVID-19 vaccine hesitancy among older adults in Ghana. Results in model 1 show that female participants (AOR: 0.923, CI: 0.021–0.045, p = .072) and those who have retired (AOR: 0.034, CI: 0.024–0.048, p = .000) were significantly less likely to engage in COVI-19 vaccine hesitance than their respective counterparts. In the full model, female participants (AOR: 0.734, CI: 0.019–0.036, p = .027) and those who have retired (AOR: 0.861, CI: 0.003–0.028, p = .034) were significantly less likely to engage in COVID-19 vaccine hesitance. Again, participants who trust public health information (AOR: 0.065, CI: 0.022–0.049, p = .031) and have social capital (AOR: 0.886, CI: 0.017–0.032, p = .001) were significantly less likely to present COVID-19 vaccine hesitance. Finally, participants who believe in the conspiracy theories about the COVID-19 and the vaccines (AOR: 3.167, CI: 1.021–2.043, p = .004) were significantly more likely to engage in COVID-19 vaccine hesitance than those who do not believe in the conspiracy theories about the COVID-19 and the vaccines.

Table 2.

Determinants of vaccine hesitancy among older adults.

  Model 1
Model 2/Full Model
Variable AOR 95% C.I AOR 95% C.I
Socio-Demographic Variables        
Gendera        
Female 0.923* (0.021–0.045) 0.734 (0.019–0.036)
Age (years)b        
61–70 1.452 (0.023–0.065) 0.983 (0.748–1.673)
Above 70 0.963 (0.998–1.293) 1.983 (0.886–2.963)
Marital Statusc        
Divorced 1.082 (0.043–1.093) 1.382 (0.047–1.053)
Widowed 2.253 (0.672–1.109) 1.173 (0.863–2.220)
Religious groupd        
Non-Christian 0.762 (0.783–1.783) 1.753 (0.783–1.092)
Educatione        
Basic 0.975 (0.387–1.982) 0.382 (0.983–1.072)
Secondary or high school 2.096 (0.298–1.982) 0.653 (0.054–0.352)
Tertiary 0.963 (0.017–2.256) 0.988 (0.064–0.836)
Employment Statusf        
Retired 0.034* (0.024–0.048) 0.861* (0.003–0.028)
Socio-economic statusg        
Quite poor 1.823 (0.398–0.036) 0.516 (0.246–0.083)
Not very well off 2.073 (0.083–0.392) 0.440 (0.159–0.221)
Quite well off 0732 (0.054–0.972) 0.805 (0.124–0.776)
Trust in health information and social capital-related variables        
Believe in conspiracy theoriesh     3.167* (1.021–2.043)
Trust in public health informationi     0.065* (0.022–0.049)
Social capitalj     0.886* (0.017–0.032)
Model fitting information
−2Log Likelihood
  2673.096   367.982
Hosmer-Lemeshow χ2 (significance)   11.23(0.006)   7.781(0.025)
Nagelkerke R2   0.253   0.063

* p ˂ .05.

aMale is the reference category for the gender variable.

b50–60 years is the reference category for the age variable

cMarried is the reference category for the marital status variable.

dChristian is the reference category for religious variables.

eNo formal education is the reference category for the education variable.

fEmployed is the reference group for the employment variable.

gExtremely poor is the reference category for socio-economic status.

hYes is the reference group for the belief in conspiracy theories variable.

iYes is the reference group for the trust in health information variable.

jYes is the reference group for the social capital variable.

Model 1 = Socio-Demographic variables; Model 2 = All variables in Model 1 plus Trust in health information and social capital-related variables.

CI = Confidence Interval; OR = Odd Ratio = AOR = Adjusted Odd Ratio.

Discussion

Female older adults demonstrate lower likelihood towards COVID-19 vaccine hesitance than males. This is contrary to earlier studies in Ghana within the general population more males were ready to participate in the COVID-19 vaccine trial and the uptake of the vaccine than females.33,56 Similar findings were reported in other countries among the general population,57 healthcare workers [HCWs]58 and older adults.59 The finding of this study significantly support that of Lazarus et al.21 who found gender differences in their global analysis of COVID-19 vaccine uptake. In their study, males were less likely to accept the COVID-19 vaccine. In Japan, COVID-19 vaccine hesitancy was found to be associated with being a female.60 Several studies have associated the higher likelihood of COVID-19 vaccine uptake and non-hesitance behavior among males with the higher risks of hospitalization from COVID-19, infection and deaths among males.61–63 The tendency to escape these ills of the pandemic predisposes males to accept the vaccine at a higher rate than females, hence the lower likelihood of vaccine hesitance. Like the aforementioned studies, there is a higher infection, hospitalization, and death rate among males compared to females in Ghana.64 Thus, the lower vaccine hesitance among the females in comparison to the male older adults is rather surprising, within the Ghanaian context. Issues relating to healthy children, particularly for breastfeeding mothers is also a factor for the lower willingness to accept vaccine among females.65,66 Such a justification does not hold within our study sample (since female older adults do not reproduce at that age), albeit, it will be interesting for future research to uncover the reasons for this occurrence. Measures to reduce COVID-19 vaccine hesitancy among males are highly recommended, as the gender dimension of vaccine hesitancy, although possibly superficial, warrants attention.

The study again revealed that older adults who have retired were less likely to develop COVID-19 vaccine hesitance than those actively employed. Interestingly, the result affirms evidence from the USA, where unemployed adults [18 years and above] reported higher COVID-19 vaccine hesitance when matched against adults who were employed.67 In the same study by,67 retired adults were less likely to accept the vaccine. Our finding confirms that of Alqudeimat et al.68 on the determinants of COVID-19 vaccine hesitance among the adult population in Kuwait. In that study, retired adults had lower odds of accepting the COVID-19 vaccine compared to other groups.68 The lower willingness of retired older adults to take the vaccine could be explained by the less obligation placed on them by their employer(s) to take the vaccine, as compared to their counterparts who are in active employment. In Ghana like many other parts of the world, workplaces have opted for compulsory vaccination as a measure to protect their employees and maintain their workforce through these turbulent times.69 Older adults in active employment are also required to comply with such directives, making them more predisposed to accepting the vaccine, hence less vaccine hesitance than older adults out of active employment [retired]. We recommend that awareness creation and the institution of measures and interventions that promote vaccination among retired older adults are given much premium, since many retired older adults may have comorbid conditions,70 which could put them at higher risks of contracting the virus and suffering the worst consequences.

Several conspiracy theories have developed in the public domain to explain the occurrence of COVID-1971 and to some extent causing fear and preventing people from engaging in certain behaviors [like the uptake of the vaccines developed]. These misconceptions are numerous. They relate to the radiation emitted through the 5 G transmitters,72 an attempt by influential people to install tracking chips on people through vaccination . Others include injecting people with some harmful coronaviruses created in labs through vaccination programmes,72 and the prophecy in Chapter 13 of Revelation (19, 20) where the mark of the beast, will be introduced into humans via injections concealed as a cure for COVID-19. However, mobile wireless technology has progressed from 1 G to 4 G, with no solid scientific proof of harmful side effects of radiation on human health. Again, these theories have exposed misconceptions about what vaccines are and how they are licensed for public use. Despite the lack of substance in these misconceptions71,72 they are continuously shared on various platforms like Facebook, Twitter, and WhatsApp among others.

According to Islam et al.37 and Hornsey et al.73 belief in anti-vaccine conspiracy theories reduces vaccination intentions and increases vaccine hesitancy. We found that older adults who believe in conspiracy theories about COVID-19 vaccination were more likely to develop hesitancy toward the COVID-19 vaccination. This implies that belief in conspiracy theory increases COVID-19 vaccine hesitance, thereby, adversely affecting the attitudes, subjective norms, and eventual uptake of the vaccine.74–77 While recognizing that copious contextual, social and vaccine-related factors can stimulate vaccine hesitance, including the prospect of getting the virus and risk perceptions toward the vaccine,78 the uncorroborated assertions of morbidity and mortality connected to the COVID-19 vaccine circulating within the public domain may affect COVID-19 vaccine confidence. These rumors could build mistrust and negative attitude toward vaccination efforts, such as vaccine hesitance. Given this, we propose an Integrated Communication and Information Dissemination Strategy (ICIDS) to lessen the undesirable consequence of misconceptions about the COVID-19 vaccine, particularly among older adults. ICIDS should be developed to entail disseminating information via presentations, publications, social media, a project website, and other channels and through workshops, round tables, and events in a two-way communication method. This should take into account the target audiences and how and where to interact with them to achieve the desired results in terms of clarifying misconceptions about COVID-19 vaccines and future vaccines. As noted by Yang, Luo and Jia,77 vaccine literacy (people’s knowledge of vaccines) plays an important role in the influence of conspiracy theories and vaccine hesitance behaviours. Public health information should also include vaccine education, with the view to increasing vaccine literacy.

We found trust in public health information to be associated with lower vaccine hesitance among older adults in Ghana. In the USA, HPV vaccination hesitance was not predicted by trust in health information from a doctor or other health experts.79 The association between confidence in government health information and vaccination hesitance was somewhat mediated by perceived vaccine effectiveness, according to mediation studies.79 This finding supports our results, as the degree to which people trust sources of information may influence how they respond to public health policies.80,81 Past evidence on trust in public health information and vaccine hesitance for influenza vaccination,82 hepatitis B vaccination,83 and H1N1 vaccination84 reveal that lower trust leads to vaccine hesitancy. Thus, mistrust of public health information leads to lower vaccine hesitance. Since hesitance to vaccinate is associated with a lack of trust in authorities and scientists,85–87 we recommend that traditional risk communication and community participation techniques be explored. Again, caveats are attached to information about vaccines that are inconclusive, to make amendments easy and less exposed to misinterpretations that breed mistrust. To close this gap, public trust must be developed with all stakeholders to recognize the benefit of vaccinations in their own social, cultural, and political settings. Vaccine information should be transparent in revealing both the threats and benefits of vaccinations, as well as ensuring the public that vaccines are safe and effective. In vaccination communication, people’s confidence in the information source, style of communication, and message consistency should be examined. These may hold the key to closing the vaccine confidence gap.

The idea of social capital has been established to include the value of a community structure.88,89 To better reflect the nature of communities, social capital has been described as the quality of relationships among community members, as indicated by trust and reciprocal help that benefits all parties.28 Previous research has demonstrated that increased social capital leads to increased vaccine uptake and lower vaccine hesitance.29–31 According to these researches, the stronger the linking social capital in the form of confidence in the health system, the better the vaccination hesitance. Our finding of lower vaccine hesitance among older people with social support is similar to that of Ferwana and Varshney25 who found that community vaccination as a dimension of social capital is negatively associated with vaccine hesitancy. Furthermore, among slum residents in Salvador, Brazil, Aguilar Ticona et al.26 established that COVID-19 vaccine hesitancy was associated with low social capital. Cohesiveness or social capital does not arise in a vacuum. They are created as a result of social interaction between individuals and have a reciprocal impact on their daily lives. In every environment, there is no one-size-fits-all method for increasing social capital. More research is needed to understand how social capital is formed within the complicated social structure among older adults. Increasing social cohesiveness could have a significant positive impact on COVID-19 vaccine hesitance. In the design of communication efforts to promote COVID-19 vaccination uptake by addressing factors that increase vaccine hesitance among older adults, social capital provides a key opportunity, which must be explored.

Strengths and limitations

To the best knowledge of the authors, this is the first study that examined the link between social capital and COVID-19 vaccine hesitancy in Ghana, particularly among older adults. Another feature of the study is its timeliness since it documented the social dynamics surrounding the COVID-19 vaccination campaign during and soon after the vaccination campaign. It offers the prospect of integrating results from this study into the vaccine rollout and future vaccination programs in Ghana and beyond. Finally, we integrated personal, social and institutional factors that influence vaccine hesitance among older adults (a group with severe risk factors, relative to COVID-19) to develop a robust decision-making tool to guide institutions and persons in charge of the vaccination program in Ghana.

By way of limitations, our study’s cross-sectional methodology is a significant disadvantage, especially given that attitudes toward COVID-19 vaccination are expected to change swiftly. Furthermore, the respondents came from two geographic locations, which may have influenced the generalizability of the survey results. Again, purposive sampling is susceptible to study bias, much like other non-probability sampling methods. Results have a significant risk of bias since the sample units are chosen based on the researcher’s subjective evaluation, notably observer bias. As a result, sampling bias results from the fact that not every person in the population has an equal probability of being picked for the sample. Since the respondents were recruited using purposive and snowball sampling techniques, the final sample is not representative of Ghana’s population of older adults. Finally, information about available vaccines, as well as other critical factors influencing vaccine hesitance, was not investigated. This might have concealed critical information; consequently, future studies should address these challenges as the pandemic and vaccination programs progress.

Conclusion

Contributing to the resolution of current and future pandemics, understanding the determinants of COVID-19 vaccine hesitance among older adults is crucial. In this study, we modeled the influence of socio-demographics, trust in public health information, belief in conspiracy theories and social on COVID-19 vaccine hesitance among older adults [50 years and above] in Ghana. Females, retired older adults, those without social capital, and those who do not trust public health information engage in COVID-19 vaccination hesitance. However, those who do not believe in conspiracies and misconceptions about the vaccine had higher odds of accepting it. In the design of communication efforts to promote COVID-19 vaccination uptake, social capital provides a key opportunity. Future efforts should reach out to older adults through social networks to disseminate trustworthy information about vaccination. Our research provides a snapshot of conspiracy theory trends that have the potential to increase public skepticism about vaccinations. The variety of COVID-19 vaccine misconceptions spreading might jeopardize the deployment of COVID-19 vaccines. We proposed that conventional risk communication and community involvement strategies be employed to track and fact-check misinformation and thereby insulate individuals against potential vaccination program disruptions. Policymakers when developing risk communication and community engagement initiatives to address these concerns with evidence-based information should consider these findings. Above all, greater efforts to convey vaccination benefits and risks, as well as address issues through evidence-based information, can strengthen and preserve the public’s trust in vaccines and health systems in Ghana. Measuring and monitoring trust levels, as well as concentrating on efforts to develop trust in vaccinations, are critical steps toward closing vaccine confidence gaps among older adults in Ghana.

Funding Statement

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Abbreviations

AOR

Adjusted Odd Ratio

CI

Confidence Interval

HPV

Human Papillomavirus

HW

Healthcare Workers

ICID

Integrated Communication and Information Dissemination

MMDAs

Metropolitan, Municipal, and District Assemblies

OR

Odd Ratio

SPSS

Statistical Package for the Social Sciences

WHO

World Health Organisation

Disclosure statement

The authors declare that they have no competing interests. MAA developed the study design and proofread the final manuscript.

Ethics approval and consent to participate

Verbal informed consent was obtained from the participants by agreeing orally to participate in the study, as most could not read or write. As the dignity, safety and well-being of the interviewees were a matter of primary concern to the researchers, participation in the study was strictly voluntary, and no identifying or sensitive information was recorded.

Author contribution

AKM conceptualized, drafted and prepared the manuscript for submission. MAA contributed to reviewing and editing the manuscript. JC, AAA and SKA were involved in the study design and manuscript drafting. All authors have read and agreed to the published version of the manuscript.

Data availability statement

The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.

References

  • 1.Worldometer . Coronavirus death toll and trends – worldometer. [accessed 2023 Feb 25]. https://www.worldometers.info/coronavirus/country/ghana/.
  • 2.Morgan AK. Making COVID-19 prevention etiquette of social distancing a reality for the homeless and slum dwellers in Ghana: lessons for consideration. Local Environ. 2020;25(7):536–9. doi: 10.1080/13549839.2020.1789854. [DOI] [Google Scholar]
  • 3.Morgan AK, Awafo BA.. Lessons for averting the delayed and reduced patronage of non-COVID-19 medical services by older people in Ghana. J Gerontol Soc Work. 2020;63(6–7):728–31. doi: 10.1080/01634372.2020.1808142. [DOI] [PubMed] [Google Scholar]
  • 4.Morgan AK, Awafo BA, Quartey T. The effects of COVID-19 on global economic output and sustainability: evidence from around the world and lessons for redress. Sustain: Sci Pract Policy. 2021;17(1):77–81. doi: 10.1080/15487733.2020.1860345. [DOI] [Google Scholar]
  • 5.Morgan AK, Cobbold J, Awafo BA, Katey D, Quartey T, Ibrahim R. COVID-19 and psychological distress among older adults in Ghana. In: Gabrielli F, & Irtelli F, editors. Anxiety, uncertainty, and resilience during the pandemic period-anthropological and psychological perspectives. London (England): IntechOpen; 2021. p. 1–19. doi: 10.5772/intechopen.98277. [DOI] [Google Scholar]
  • 6.Corey L, Mascola JR, Fauci AS, Collins FS. A strategic approach to COVID-19 vaccine R&D. Science. 2020;368(6494):948–50. doi: 10.1126/science.abc5312. [DOI] [PubMed] [Google Scholar]
  • 7.Katey D, Morgan AK, Asori M, Ampofo ST, Mpobi RKJ. COVID-19 and the marginalized: an opinion piece on further measures to address COVID-19 in prisons in Sub-Saharan Africa. Int J Prison Health. 2021;17(3):373–9. doi: 10.1108/IJPH-12-2020-0101. [DOI] [PubMed] [Google Scholar]
  • 8.Krause PR, Gruber MF. Emergency use authorization of Covid vaccines—safety and efficacy follow-up considerations. N Engl J Med. 2020;383(19):e107. doi: 10.1056/NEJMp2031373. [DOI] [PubMed] [Google Scholar]
  • 9.Ledford H, Cyranoski D, Van Noorden R. The UK has approved a COVID vaccine—here’s what scientists now want to know. Nature. 2020;588(7837):205–6. doi: 10.1038/d41586-020-03441-8. [DOI] [PubMed] [Google Scholar]
  • 10.Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C, Giattino C, Rodés-Guirao L. A global database of COVID-19 vaccinations. Nature Human Behav. 2021;5(7):947–53. doi: 10.1038/s41562-021-01122-8. [DOI] [PubMed] [Google Scholar]
  • 11.World Health Organisation . Ghana [Internet]; 2023. [accessed 2023 Feb 25]. https://covid19.who.int/region/afro/country/gh.
  • 12.Thomas SJ, Moreira ED Jr, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Polack FP, Zerbini C, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N Engl J Med. 2021 Nov 4;385(19):1761–73. doi: 10.1056/NEJMoa2110345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Cavanna L, Citterio C, Toscani I. COVID-19 vaccines in cancer patients. Seropositivity and safety. Systematic review and meta-analysis. Vaccines. 2021. Sep;9(9):1048. doi: 10.3390/vaccines9091048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kaur RJ, Dutta S, Bhardwaj P, Charan J, Dhingra S, Mitra P, Singh K, Yadav D, Sharma P, Misra S. Adverse events reported from COVID-19 vaccine trials: a systematic review. Indian J Clin Biochem. 2021. Oct;36(4):427–39. doi: 10.1007/s12291-021-00968-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lin C, Tu P, Beitsch LM. Confidence and receptivity for COVID-19 vaccines: a rapid systematic review. Vaccines. 2020. Dec;9(1):16. doi: 10.3390/vaccines9010016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Opel DJ, Salmon DA, Marcuse EK. Building trust to achieve confidence in COVID-19 vaccines. JAMA Netw Open. 2020. Oct 1;3(10):e2025672. doi: 10.1001/jamanetworkopen.2020.25672. [DOI] [PubMed] [Google Scholar]
  • 17.Hoxha I, Agahi R, Bimbashi A, Aliu M, Raka L, Bajraktari I, Beqiri P, Adams LV. Higher COVID-19 vaccination rates are associated with lower COVID-19 mortality: a global analysis. Vaccines. 2022. Jan;11(1):74. doi: 10.3390/vaccines11010074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Syed Alwi SAR, Rafidah E, Zurraini A, Juslina O, Brohi IB, Lukas S. A survey on COVID-19 vaccine acceptance and concern among Malaysians. BMC Public Health. 2021. Jan;21(1):1–12. doi: 10.1186/s12889-021-11071-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.John TJ, Samuel R. Herd immunity and herd effect: new insights and definitions. Eur J Epidemiol. 2000;16(7):601–6. doi: 10.1023/A:1007626510002. [DOI] [PubMed] [Google Scholar]
  • 20.Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Mudatsir M. Acceptance of a COVID-19 vaccine in Southeast Asia: a cross-sectional study in Indonesia. Front Pub Heal. 2020. Oct 21;8:381. doi: 10.3389/fpubh.2020.00381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021. Feb;27(2):225–8. doi: 10.1038/s41591-020-1124-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Gerretsen P, Kim J, Caravaggio F, Quilty L, Sanches M, Wells S, Brown EE, Agic B, Pollock BG, Graff-Guerrero A, et al. Individual determinants of COVID-19 vaccine hesitancy. PLoS One. 2021. Nov 5;16(11):e0258462. doi: 10.1371/journal.pone.0258462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Neumann-Böhme S, Varghese NE, Sabat I, Barros PP, Brouwer W, van Exel J, Schreyögg J, Stargardt T. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ. 2020. Sep;21(7):977–82. doi: 10.1007/s10198-020-01208-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD, Fang H. Acceptance of COVID-19 Vaccination during the COVID-19 pandemic in China. Vaccines (Basel). 2020. Sep;8(3):482. doi: 10.3390/vaccines8030482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ferwana I, Varshney LR. Social capital dimensions are differentially associated with COVID-19 vaccinations, masks, and physical distancing. PLoS One. 2021. Dec 1;16(12):e0260818. doi: 10.1371/journal.pone.0260818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Aguilar Ticona JP, Nery N, Victoriano R, Fofana MO, Ribeiro GS, Giorgi E, Reis MG, Ko AI, Costa F. Willingness to get the COVID-19 vaccine among residents of slum settlements. Vaccines (Basel). 2021. Sep;9(9):951. doi: 10.3390/vaccines9090951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Soares P, Rocha JV, Moniz M, Gama A, Laires PA, Pedro AR, Dias S, Leite A, Nunes C. Factors associated with COVID-19 vaccine hesitancy. Vaccines (Basel). 2021. Mar;9(3):300. doi: 10.3390/vaccines9030300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Holt PR. Studies of calcium in food supplements in humans. Ann N Y Acad Sci. 1999. Dec 31;889(1):128–37. doi: 10.1111/j.1749-6632.1999.tb08730.x. [DOI] [PubMed] [Google Scholar]
  • 29.Larson HJ, Jarrett C, Schulz WS, Chaudhuri M, Zhou Y, Dube E, Schuster M, MacDonald NE, Wilson R. Measuring vaccine hesitancy: the development of a survey tool. Vaccine. 2015. Jul 17;33(34):4165–75. doi: 10.1016/j.vaccine.2015.04.037. [DOI] [PubMed] [Google Scholar]
  • 30.Rönnerstrand B. Social capital and immunisation against the 2009 a (H1N1) pandemic in Sweden. Scand J Public Health. 2013. Dec;41(8):853–9. doi: 10.1177/1403494813494975. [DOI] [PubMed] [Google Scholar]
  • 31.Saha S, Annear PL, Pathak S. The effect of self-help groups on access to maternal health services: evidence from rural India. Int J Equity Health. 2013. Dec;12(1):40. doi: 10.1186/1475-9276-12-36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Machida M, Kikuchi H, Kojima T, Nakamura I, Saito R, Nakaya T, Hanibuchi T, Takamiya T, Odagiri Y, Fukushima N, et al. Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study. Human Vacc Immunother. 2022. May 4;18(5):2086773. doi: 10.1080/21645515.2022.2086773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Alhassan RK, Aberese-Ako M, Doegah PT, Immurana M, Dalaba MA, Manyeh AK, Klu D, Acquah E, Ansah EK, Gyapong M. COVID-19 vaccine hesitancy among the adult population in Ghana: evidence from a pre-vaccination rollout survey. Trop Med Health. 2021. Feb 22;49(1):1–3. doi: 10.1186/s41182-021-00357-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Lamptey E, Serwaa D, Appiah AB. A nationwide survey of the potential acceptance and determinants of COVID-19 vaccines in Ghana. Clin Exp Vaccine Res. 2021. Jul;10(2):183–91. doi: 10.7774/cevr.2021.10.2.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Agyekum MW, Afrifa-Anane GF, Kyei-Arthur F, Addo B. Acceptability of COVID-19 vaccination among health care workers in Ghana. Adv Public Health. 2021. Jun 22;2021:8868462. doi: 10.1155/2021/9998176. [DOI] [Google Scholar]
  • 36.Alhassan RK, Owusu-Agyei S, Ansah EK, Gyapong M. COVID-19 vaccine uptake among health care workers in Ghana: a case for targeted vaccine deployment campaigns in the global south. Hum Resour Health. 2021. Dec;19(1):165. doi: 10.1186/s12960-021-00657-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Islam MS, Kamal AHM, Kabir A, Southern DL, Khan SH, Hasan SM, Sarkar T, Sharmin S, Das S, Roy T, et al. COVID-19 vaccine rumors and conspiracy theories: the need for cognitive inoculation against misinformation to improve vaccine adherence. PLoS One. 2021. May 26;16(5):e0251605. doi: 10.1371/journal.pone.0251605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Creswell JW. Research design. Qualitative, quantitative, and mixed methods approaches. 3rd ed. London (UK): Sage Publication; 2009. [Google Scholar]
  • 39.Creswell JW. A concise introduction to mixed methods research. Newbury Park (CA): Sage Publications; 2014. [Google Scholar]
  • 40.Gravetter FJ, Forzano LA. Research methods for the behavioral sciences. Toronto (Canada): Nelson Education; 2015. [Google Scholar]
  • 41.Kothari CR. Research methodology: methods and techniques. New age international (P) New Delhi (India): Limited Publishers; 2004. [Google Scholar]
  • 42.Hemed M. Cross-sectional studies. Training Course in Sexual and Reproductive Health Research, Geneva; 2017. https://www.gfmer.ch/SRH-Course-2017/research-methodology/pdf/Cross-sectional-studies-Hemed-2017.pdf. [Google Scholar]
  • 43.Setia MS. Methodology series module 3: cross-sectional studies. Indian J Dermatol. 2016. May-Jun;61(3):261–4. doi: 10.4103/0019-5154.182410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Levin KA. Study design III: cross-sectional studies. Evid Based Dent. 2006;7(1):24–5. doi: 10.1038/sj.ebd.6400375. [DOI] [PubMed] [Google Scholar]
  • 45.Naing L, Winn TBNR, Rusli BN. Practical issues in calculating the sample size for prevalence studies. Arch Orofac Sci. 2006;1:9–14. [Google Scholar]
  • 46.Bhattacherjee A. Social science research: principles, methods, and practices textbooks collection. Book. 3. http://scholarcommons.usf.edu/oa_textbooks/. [Google Scholar]
  • 47.Denscombe M. The good research guide for small-scale social research projects. 4th ed. England: Open University Press; 2010. [Google Scholar]
  • 48.Handcock MS, Gile KJ. Comment: on the concept of snowball sampling. Sociol Methodol. 2011;41(1):367–71. doi: 10.1111/j.1467-9531.2011.01243.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Goodman LA. Snowball sampling. Ann Math Stat. 1961;32(1):148–70. doi: 10.1214/aoms/1177705148. [DOI] [Google Scholar]
  • 50.Kumekpor T. Research methods & techniques of social research. Accra: Sonlife Press & Services; 2002. [Google Scholar]
  • 51.Dewi VI. How do demographic and socioeconomic factors affect financial literacy and its variables? Cogent Bus Manag. 2022;9(1):2077640. doi: 10.1080/23311975.2022.2077640. [DOI] [Google Scholar]
  • 52.Hoffmeyer-Zlotnik JH. Harmonisation of demographic and socio-economic variables in cross-national survey research. Bull Sociol Methodol/Bulletin de Méthodologie Sociologique. 2008;98(1):5–24. doi: 10.1177/075910630809800103. [DOI] [Google Scholar]
  • 53.Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger JA. Vaccine hesitancy: an overview. Human Vacc Immunother. 2013;9(8):1763–73. doi: 10.4161/hv.24657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4. doi: 10.1016/j.vaccine.2015.04.036. [DOI] [PubMed] [Google Scholar]
  • 55.Coontz PD. Ethics in systematic research. In: Miller J, and Whicker L, editors. Handbook of research methods in public administration. New York: Arcel Dekker, Inc; 1999. p. 3–20 [Google Scholar]
  • 56.Kaadan MI, Abdulkarim J, Chaar M, Zayegh O, Keblawi MA. Determinants of COVID-19 vaccine acceptance in the Arab world: a cross-sectional study. Glob Health Res Policy. 2021;6(1):1–7. doi: 10.1186/s41256-021-00202-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.El-Elimat T, AbuAlsamen MM, Almomani BA, Al-Sawalha NA, Alali FQ. Acceptance and attitudes toward COVID-19 vaccines: a cross-sectional study from Jordan. PLoS One. 2021;16(4):e0250555. doi: 10.1371/journal.pone.0250555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Elharake JA, Galal B, Alqahtani SA, Kattan RF, Barry MA, Temsah MH, Malik AA, McFadden SM, Yildirim I, Khoshnood K, et al. COVID-19 vaccine acceptance among health care workers in the Kingdom of Saudi Arabia. Int J Infect Dis. 2021;109:286–93. doi: 10.1016/j.ijid.2021.07.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Al-Hanawi MK, Alshareef N, El-Sokkary RH. Willingness to receive COVID-19 vaccination among older adults in Saudi Arabia: a community-based survey. Vaccines. 2021;9(11):1257. doi: 10.3390/vaccines9111257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Okubo R, Yoshioka T, Ohfuji S, Matsuo T, Tabuchi T. COVID-19 vaccine hesitancy and its associated factors in Japan. Vaccines. 2021;9(6):662. doi: 10.3390/vaccines9060662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13. doi: 10.1016/S0140-6736(20)30211-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Galbadage T, Peterson BM, Wang DC, Wang JS, Gunasekera RS. Biopsychosocial and spiritual implications of patients with COVID-19 dying in isolation. Front Psychol. 2020;11:588623. doi: 10.3389/fpsyg.2020.588623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Peckham H, de Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, Rosser EC, Webb K, Deakin CT. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020;11(1):6317. doi: 10.1038/s41467-020-19741-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Ghana Health Service . COVID-19 updates in Ghana - Ghana health service [Internet]. [accessed 2022 Jan 31]. https://www.ghs.gov.gh/covid19/dashboardm.php.
  • 65.Garg D, Muthu V, Sehgal IS, Ramachandran R, Kaur H, Bhalla A, Puri GD, Chakrabarti A, Agarwal R. Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia. 2021;186(2):289–98. doi: 10.1007/s11046-021-00528-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.McLaurin-Jiang S, Garner CD, Krutsch K, Hale TW. Maternal and child symptoms following COVID-19 vaccination among breastfeeding mothers. Breastfeed Med. 2021;16(9):702–9. doi: 10.1089/bfm.2021.0079. [DOI] [PubMed] [Google Scholar]
  • 67.Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020;26:100495. doi: 10.1016/j.eclinm.2020.100495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Alqudeimat Y, Alenezi D, AlHajri B, Alfouzan H, Almokhaizeem Z, Altamimi S, Almansouri W, Alzalzalah S, Ziyab AH. Acceptance of a COVID-19 vaccine and its related determinants among the general adult population in Kuwait. Med Princ Pract. 2021;30(3):262–71. doi: 10.1159/000514636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Leask J, Seale H, Williams JH, Kaufman J, Wiley K, Mahimbo A, Clark KK, Danchin MH, Attwell K. Policy considerations for mandatory COVID‐19 vaccination from the collaboration on social science and immunisation. Med J Aust. 2021;215(11):499–503. doi: 10.5694/mja2.51269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Caplan B, Bogner J, Brenner L, Malec J, Kumar RG, Juengst SB, Wang Z, Dams-O’Connor K, Dikmen SS, O’Neil-Pirozzi TM, et al. Epidemiology of comorbid conditions among adults 50 years and older with traumatic brain injury. J Head Trauma Rehabil. 2018;33(1):15–24. doi: 10.1097/HTR.0000000000000273. [DOI] [PubMed] [Google Scholar]
  • 71.Mejova Y, Kalimeri K. COVID-19 on Facebook ads: competing agendas around a public health crisis. Proceedings of the 3rd ACM SIGCAS Conference on Computing and Sustainable Societies. New York (NY): Ecuador, ACM; 2020. p. 22–31. [Google Scholar]
  • 72.Nyika A, Nyika GT, Nyika JT, Nyika JT, Nyika T. COVID-19 pandemic: questioning conspiracy theories, beliefs or claims that have potential negative impact on public health interventions and proposal for Integrated Communication and Information Dissemination Strategies (ICIDS). J Dev Commun Stud. 2021;8(1):1–21. doi: 10.4314/jdcs.v8i1.1. [DOI] [Google Scholar]
  • 73.Hornsey MJ, Harris EA, Fielding KS. The psychological roots of anti-vaccination attitudes: a 24-nation investigation. Health Psychol. 2018;37(4):307. doi: 10.1037/hea0000586. [DOI] [PubMed] [Google Scholar]
  • 74.Akther T, Nur T. A model of factors influencing COVID-19 vaccine acceptance: a synthesis of the theory of reasoned action, conspiracy theory belief, awareness, perceived usefulness, and perceived ease of use. Plos One. 2022;17(1):e0261869. doi: 10.1371/journal.pone.0261869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Pivetti M, Di Battista S, Paleari FG, Hakoköngäs E. Conspiracy beliefs and attitudes toward COVID-19 vaccinations: a conceptual replication study in Finland. J Pac Rim Psychol. 2021;15:18344909211039893. doi: 10.1177/18344909211039893. [DOI] [Google Scholar]
  • 76.Soveri A, Karlsson LC, Antfolk J, Lindfelt M, Lewandowsky S. Unwillingness to engage in behaviors that protect against COVID-19: the role of conspiracy beliefs, trust, and endorsement of complementary and alternative medicine. BMC Public Health. 2021;21(1):1–12. doi: 10.1186/s12889-021-10643-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Yang Z, Luo X, Jia H. Is it all a conspiracy? Conspiracy theories and people’s attitude to COVID-19 vaccination. Vaccines. 2021;9(10):1051. doi: 10.3390/vaccines9101051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Brewer NT, Chapman GB, Rothman AJ, Leask J, Kempe A. Increasing vaccination: putting psychological science into action. Psychol Sci Public Interest. 2017;18(3):149–207. doi: 10.1177/1529100618760521. [DOI] [PubMed] [Google Scholar]
  • 79.Nan X, Daily K, Richards A, Holt C, Wang MQ, Tracy K, Qin Y. The role of trust in health information from medical authorities in accepting the HPV vaccine among African American parents. Hum Vaccin Immunother. 2019;15(7–8):1723–31. doi: 10.1080/21645515.2018.1540825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Fridman I, Lucas N, Henke D, Zigler CK. Association between public knowledge about COVID-19, trust in information sources, and adherence to social distancing: cross-sectional survey. JMIR Public Health Surveill. 2020;6(3):e22060. doi: 10.2196/22060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Vinck P, Pham PN, Bindu KK, Bedford J, Nilles EJ. Institutional trust and misinformation in the response to the 2018–19 Ebola outbreak in North Kivu, DR Congo: a population-based survey. Lancet Infect Dis. 2019;19(5):529–36. doi: 10.1016/S1473-3099(19)30063-5. [DOI] [PubMed] [Google Scholar]
  • 82.Telford R, Rogers A. What influences elderly peoples’ decisions about whether to accept the influenza vaccination? A qualitative study. Health Educ Res. 2003;18(6):743–53. doi: 10.1093/her/cyf059. [DOI] [PubMed] [Google Scholar]
  • 83.Samoff E, Dunn A, VanDevanter N, Blank S, Weisfuse IB. Predictors of acceptance of hepatitis B vaccination in an urban sexually transmitted diseases clinic. Sex Transm Dis. 2004;31(7):415–20. doi: 10.1097/01.OLQ.0000130533.53987.78. [DOI] [PubMed] [Google Scholar]
  • 84.Esteves-Jaramillo A, Omer SB, Gonzalez-Diaz E, Salmon DA, Hixson B, Navarro F, Kawa-Karasik S, Frew P, Morfin-Otero R, Rodriguez-Noriega E, et al. Acceptance of a vaccine against novel influenza a (H1N1) virus among health care workers in two major cities in Mexico. Arch Med Res. 2009;40(8):705–11. doi: 10.1016/j.arcmed.2010.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Callaghan T, Moghtaderi A, Lueck JA, Hotez P, Strych U, Dor A, Fowler EF, Motta M. Correlates and disparities of intention to vaccinate against COVID-19. Soc Sci Med (1982). 2021;272:113638. doi: 10.1016/j.socscimed.2020.113638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Lindholt MF, Jørgensen F, Bor A, Petersen MB. Public acceptance of COVID-19 vaccines: cross-national evidence on levels and individual-level predictors using observational data. BMJ Open. 2021. Jun;11(6):e048172. doi: 10.1136/bmjopen-2020-048172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Roozenbeek J, Schneider CR, Dryhurst S, Kerr J, Freeman AL, Recchia G, van der Bles AM, van der Linden S. Susceptibility to misinformation about COVID-19 around the world. R Soc Open Sci. 2020. Oct 7;7(10):201199. doi: 10.1098/rsos.201199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Coleman JS. Capital social y creación de capital humano. Zona abierta. 2001;94:47–81. [Google Scholar]
  • 89.Putnam R. Bowling alone: America’s declining social capital. J Democr. 1995. Jan;6(1):65–78. doi: 10.1353/jod.1995.0002. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.


Articles from Human Vaccines & Immunotherapeutics are provided here courtesy of Taylor & Francis

RESOURCES